Gene · 5817
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chronic obstructive pulmonary disease reprograms the lung into an immune organ through trained immunity, cell death networks, and immune checkpoint dysregulation. | Front Med (Lausanne) | 2026 | 41684927 | PubTator, text mining | PubMed |
| Targeting NgR1/NogoA Signalling Enhances Natural Killer Cell Cytotoxicity and Alters Immune and Oncogenic Pathways in TNBC Cells. | Scand J Immunol | 2026 | 41681012 | PubTator, text mining | PubMed |
| Exploring the Role Of CD155 in Urothelial Carcinoma of the Urinary Bladder: An Immunohistochemical Study & Its Correlation With PD-L1. | Asian Pac J Cancer Prev | 2026 | 41660925 | PubTator, text mining | PubMed |
| T Cell Exhaustion in Hepatocellular Carcinoma: A Substantial Barrier in Immunotherapy. | J Cell Mol Med | 2026 | 41645702 | PubTator, text mining | PubMed |
| Isolation of Pure Stable Human Treg Cells Based on Expression of GPA33. | Eur J Immunol | 2026 | 41645582 | PubTator, text mining | PubMed |
| Determination of cardiac output, shunt-fraction, and active circulatory volume in children with hypoplastic left heart syndrome after the Norwood procedure with RV to PA-shunt. | Sci Rep | 2026 | 41639294 | PubTator, text mining | PubMed |
| Oncolytic viruses: advanced strategies in cancer therapy. | Signal Transduct Target Ther | 2026 | 41639062 | PubTator, text mining | PubMed |
| Tiny tools closing the gap: nanobodies in research and therapy. | Function (Oxf) | 2026 | 41627946 | PubTator, text mining | PubMed |
| Drug strategies for the treatment and prevention of proliferative vitreoretinopathy: an overview of innovative treatment concepts. | Int Ophthalmol | 2026 | 41619046 | PubTator, text mining | PubMed |
| Stem cell engineering for the generation of allogeneic CAR-directed natural killer T cells targeting endometrial carcinoma. | Exp Hematol Oncol | 2026 | 41612507 | PubTator, text mining | PubMed |
| Association of TIGIT and CD155 with KRAS, NRAS, BRAF, PIK3CA, and AKT Gene Mutations, MSI Status, and Cytokine Profiles in Colorectal Cancer. | Int J Mol Sci | 2026 | 41596586 | PubTator, text mining | PubMed |
| Poliovirus Receptor as a Potential Target in Gastric Signet-Ring Cell Carcinoma for Antibody-Drug Conjugate Development. | Cancers (Basel) | 2026 | 41595191 | PubTator, text mining | PubMed |
| Dual targeting of CD155 augments the antitumor efficacy of ROR1-CAR-T cells in ovarian cancer. | Cancer Immunol Immunother | 2026 | 41591545 | PubTator, text mining | PubMed |
| Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications. | Signal Transduct Target Ther | 2026 | 41582215 | PubTator, text mining | PubMed |
| DSP502 Combines Dual Inhibition of PD-L1 and PVR to Trigger Anticancer Immune Responses. | Mol Cancer Ther | 2026 | 41578832 | PubTator, text mining | PubMed |
| Relationship of Pulmonary Artery to Aorta Ratio With Pulmonary Vascular Resistance, Compliance, and Outcomes in COPD and Interstitial Lung Disease in PVDOMICS. | Pulm Circ | 2026 | 41567752 | PubTator, text mining | PubMed |
| Evaluating prostate biopsy practices across Indian institutions: A multi-center prospective observational study. | Indian J Urol | 2026 | 41562011 | PubTator, text mining | PubMed |
| Progress in perioperative immunotherapy for lung cancer and analysis of therapy (Review). | Oncol Lett | 2026 | 41560977 | PubTator, text mining | PubMed |
| Triplet regimens for frontline treatment of CLL-Great company or just a crowd? | Hemasphere | 2026 | 41560849 | PubTator, text mining | PubMed |
| Prognostic Value of Acute Vasoreactivity in Chronic Thromboembolic Pulmonary Hypertension. | Pulm Circ | 2026 | 41555850 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5817/papers?page=8